| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 278.55B | 262.73B | 197.43B | 185.96B | 162.93B | 157.71B |
| Gross Profit | 49.36B | 40.33B | 25.45B | 22.14B | 20.27B | 21.04B |
| EBITDA | 32.25B | 24.13B | 11.64B | 8.92B | 8.03B | 9.24B |
| Net Income | 23.02B | 17.44B | 9.09B | 6.63B | 5.78B | 6.32B |
Balance Sheet | ||||||
| Total Assets | 181.87B | 218.59B | 162.67B | 150.20B | 140.64B | 134.08B |
| Cash, Cash Equivalents and Short-Term Investments | 45.48B | 51.76B | 22.70B | 25.38B | 16.07B | 31.77B |
| Total Debt | 3.38B | 23.60B | 3.16B | 3.62B | 3.90B | 5.18B |
| Total Liabilities | 71.23B | 109.38B | 68.68B | 67.78B | 63.40B | 59.24B |
| Stockholders Equity | 108.51B | 107.02B | 93.75B | 82.24B | 77.08B | 74.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 12.06B | -1.03B | 14.13B | -12.94B | 13.87B |
| Operating Cash Flow | 0.00 | 12.40B | 596.00M | 15.94B | -11.72B | 14.24B |
| Investing Cash Flow | 0.00 | -832.00M | -603.00M | -4.73B | -873.00M | -718.00M |
| Financing Cash Flow | 0.00 | 16.04B | -2.83B | -2.22B | -3.21B | -3.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥386.28B | 12.03 | ― | 2.58% | 30.13% | 101.75% | |
76 Outperform | ¥257.11B | 12.19 | 7.43% | 2.78% | 1.31% | 59.20% | |
74 Outperform | ¥595.17B | 13.52 | 8.34% | 2.66% | 5.14% | 12.52% | |
72 Outperform | ¥687.91B | 12.93 | ― | 2.15% | -5.20% | -1.20% | |
71 Outperform | ¥182.16B | 9.99 | ― | 2.87% | 6.66% | 46.38% | |
70 Outperform | ¥544.51B | 14.38 | ― | 2.51% | 15.47% | 64.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |